Maquet Getinge Group   Report issue

For profit Phase 1 Phase 2
Founded: Getinge Sweden (1838)
Status: No NME R&D (1838)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

Key: Maquet Getinge Group (0) Acquired (1)

dl-2-(difluoromethyl) ornithine (1 trial)

Drugs in Phase 1 Trials (1)

Key: Maquet Getinge Group (0) Acquired (1)

ex vivo activated immune cells (1 trial)

Drugs in Other Trials (1)

Key: Maquet Getinge Group (0) Acquired (1)

abciximab (Reopro) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 3